Copy Number Aberrations of Multiple Genes Identified as Prognostic Markers for Extrahepatic Metastasis-free Survival of Patients with Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Copy Number Aberrations of Multiple Genes Identified as Prognostic Markers for Extrahepatic Metastasis-free Survival of Patients with Hepatocellular Carcinoma

Published:2019-10 Issue:5 Volume:39 Page:759-765
ISSN:2096-5230
Container-title:Current Medical Science
language:en
Short-container-title:CURR MED SCI

Author:

Zhu Zhong-zheng,Bao Ling-ling,Zhao Kun,Xu Qing,Zhu Jia-yi,Zhu Ke-xuan,Wen Bing-ji,Ye Ying-quan,Wan Xiao-xi,Wang Liang-liang,He Song-qin,Cong Wen-ming

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s11596-019-2103-6.pdf

Reference31 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin, 2017,67(1):7–30

2. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016,66(2):115–132

3. Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet, 2005,37 Suppl:S11–17

4. Beroukhim R, Mermel CH, Porter D, et al. The landscape of somatic copy-number alteration across human cancers. Nature, 2010,463(7283):899–905

5. Ali H, Bitar MS, Al Madhoun A, et al. Functionally-focused algorithmic analysis of high resolution microarray-CGH genomic landscapes demonstrates comparable genomic copy number aberrations in MSI and MSS sporadic colorectal cancer. PLoS One, 2017,12(2):e0171690

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive assessment of regulatory T-cells-related scoring system for predicting the prognosis, immune microenvironment and therapeutic response in hepatocellular carcinoma;Aging;2024-03-08

2. Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making;Hepatology;2023-06-12

3. Hepatocellular Carcinoma Gene Expression: The New Era, Where It goes?;iLIVER;2023-03

4. Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma;Biomedicines;2022-09-14

5. Correlating genomic copy number alterations with clinicopathologic findings in 75 cases of hepatocellular carcinoma;BMC Medical Genomics;2021-06-08